NO992933L - Cykloalkyl-inhibitorer for protein-farnesyltransferase - Google Patents

Cykloalkyl-inhibitorer for protein-farnesyltransferase

Info

Publication number
NO992933L
NO992933L NO992933A NO992933A NO992933L NO 992933 L NO992933 L NO 992933L NO 992933 A NO992933 A NO 992933A NO 992933 A NO992933 A NO 992933A NO 992933 L NO992933 L NO 992933L
Authority
NO
Norway
Prior art keywords
farnesyl transferase
protein farnesyl
inhibitors
cycloalkyl
cycloalkyl inhibitors
Prior art date
Application number
NO992933A
Other languages
English (en)
Norwegian (no)
Other versions
NO992933D0 (no
Inventor
Anette Marian Doherty
James Stanley Kaltenbronn
Daniele Marie Leonard
Dennis Joseph Mcnamara
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO992933D0 publication Critical patent/NO992933D0/no
Publication of NO992933L publication Critical patent/NO992933L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO992933A 1996-12-17 1999-06-16 Cykloalkyl-inhibitorer for protein-farnesyltransferase NO992933L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3366196P 1996-12-17 1996-12-17
US5683197P 1997-08-22 1997-08-22
PCT/US1997/023280 WO1998027109A1 (en) 1996-12-17 1997-12-16 Cycloalkyl inhibitors of protein farnesyltransferase

Publications (2)

Publication Number Publication Date
NO992933D0 NO992933D0 (no) 1999-06-16
NO992933L true NO992933L (no) 1999-06-16

Family

ID=26709973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992933A NO992933L (no) 1996-12-17 1999-06-16 Cykloalkyl-inhibitorer for protein-farnesyltransferase

Country Status (21)

Country Link
US (1) US6281194B1 (ko)
EP (1) EP0951471B1 (ko)
JP (1) JP2001506265A (ko)
KR (1) KR20000057601A (ko)
AT (1) ATE261987T1 (ko)
AU (1) AU721786C (ko)
BR (1) BR9713744A (ko)
CA (1) CA2264207A1 (ko)
CO (1) CO4920227A1 (ko)
DE (1) DE69728165T2 (ko)
DK (1) DK0951471T3 (ko)
ES (1) ES2216189T3 (ko)
HR (1) HRP970693B1 (ko)
ID (1) ID19142A (ko)
IL (1) IL128546A0 (ko)
NO (1) NO992933L (ko)
NZ (1) NZ334702A (ko)
PE (1) PE46999A1 (ko)
PT (1) PT951471E (ko)
TW (1) TW552259B (ko)
WO (1) WO1998027109A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0951471B1 (en) 1996-12-17 2004-03-17 Warner-Lambert Company Llc Cycloalkyl inhibitors of protein farnesyltransferase
US6369034B1 (en) 1998-04-27 2002-04-09 Warner-Lambert Company Functionalized alkyl and alenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EP1427418B1 (en) * 2001-08-24 2009-11-11 Yale University Piperazinone compounds as anti-tumor and anti-cancer agents
AU2007229363B2 (en) * 2001-08-24 2009-06-04 University Of South Florida Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment
WO2005049589A2 (en) * 2003-10-14 2005-06-02 Cadila Healthcare Limited Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3597863B2 (ja) * 1993-11-05 2004-12-08 ワーナー−ランバート・コンパニー タンパク質:ファルネシルトランスフェラーゼの置換されたジ‐およびトリペプチド阻害剤
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
EP0951471B1 (en) 1996-12-17 2004-03-17 Warner-Lambert Company Llc Cycloalkyl inhibitors of protein farnesyltransferase

Also Published As

Publication number Publication date
EP0951471A1 (en) 1999-10-27
HRP970693B1 (en) 2002-06-30
PE46999A1 (es) 1999-05-20
CO4920227A1 (es) 2000-05-29
HRP970693A2 (en) 1998-10-31
ID19142A (id) 1998-06-18
DE69728165T2 (de) 2005-01-20
JP2001506265A (ja) 2001-05-15
US6281194B1 (en) 2001-08-28
WO1998027109A1 (en) 1998-06-25
ES2216189T3 (es) 2004-10-16
ATE261987T1 (de) 2004-04-15
NO992933D0 (no) 1999-06-16
AU721786B2 (en) 2000-07-13
EP0951471B1 (en) 2004-03-17
BR9713744A (pt) 2000-03-21
DK0951471T3 (da) 2004-07-19
AU721786C (en) 2001-08-02
CA2264207A1 (en) 1998-06-25
IL128546A0 (en) 2000-01-31
TW552259B (en) 2003-09-11
AU5899098A (en) 1998-07-15
KR20000057601A (ko) 2000-09-25
DE69728165D1 (de) 2004-04-22
NZ334702A (en) 2000-11-24
PT951471E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
ATE200085T1 (de) Histidine und homohistidine derivate zur verwendung als protein farnesyltransferase hemmstoffe
DE69427127D1 (de) Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
ES2173887T3 (es) Nuevos usos farmaceuticos de las enzimas de krill.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
NO992933D0 (no) Cykloalkyl-inhibitorer for protein-farnesyltransferase
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
AU2821000A (en) Matrix protein compositions for induction of apoptosis
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.
ECSP972339A (es) Inhibidores de cicloalquilo de la farnesil transferasa de las proteinas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application